For the year ending 2025-12-31, PRA had -$18,387K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net premiums earned | 934,236 |
| Net investment income | 156,498 |
| Operating Segments-Specialty Propertyand Casualty | 0 |
| Operating Segments-Workers Compensation Insurance Segment | 0 |
| Operating Segments-Segregated Portfolio Cell Reinsurance | 0 |
| Corporate-Operating Segments | 16,276 |
| Intersegment Elimination | 0 |
| Equity in earnings (loss) of unconsolidated subsidiaries | 16,276 |
| Net investment gains (losses) | -5,486 |
| Other income (expense) | -3,496 |
| Net losses and loss adjustment expenses | 665,418 |
| Operating expenses | 182,748 |
| Deferred policy acquisition costs amortization | 131,318 |
| Operating Segments-Specialty Propertyand Casualty | 0 |
| Operating Segments-Workers Compensation Insurance Segment | 0 |
| Operating Segments-Segregated Portfolio Cell Reinsurance | 2,413 |
| Corporate-Operating Segments | 0 |
| Intersegment Elimination | 0 |
| Spc u.s. federal income tax benefit (expense) | 2,413 |
| Operating Segments-Specialty Propertyand Casualty | 0 |
| Operating Segments-Workers Compensation Insurance Segment | 0 |
| Operating Segments-Segregated Portfolio Cell Reinsurance | 6,873 |
| Corporate-Operating Segments | 0 |
| Intersegment Elimination | 0 |
| Spc dividend (expense) income | 6,873 |
| Operating Segments-Specialty Propertyand Casualty | 0 |
| Operating Segments-Workers Compensation Insurance Segment | 0 |
| Operating Segments-Segregated Portfolio Cell Reinsurance | 0 |
| Corporate-Operating Segments | 20,838 |
| Intersegment Elimination | 0 |
| Interest expense | 20,838 |
| Operating Segments-Specialty Propertyand Casualty | 0 |
| Operating Segments-Workers Compensation Insurance Segment | 0 |
| Operating Segments-Segregated Portfolio Cell Reinsurance | 0 |
| Corporate-Operating Segments | 22,229 |
| Intersegment Elimination | 0 |
| Income tax benefit (expense) | 22,229 |
| Segment results | 66,191 |
| Transaction-related costs, net-Material Reconciling Items | -15,276 |
| Net income (loss) | 50,915 |
| Goodwill impairment | 0 |
| Depreciation and amortization, net of accretion | 13,689 |
| (increase) decrease in cash surrender value of boli | 2,608 |
| Gain on sale of capital assets | 2,212 |
| Net investment (gains) losses | -5,486 |
| Share-based compensation | 7,849 |
| Deferred income tax expense (benefit) | 16,788 |
| Policy acquisition costs, net of amortization (net deferral) | -1,735 |
| Equity in (earnings) loss of unconsolidated subsidiaries | 16,276 |
| Distributed earnings from unconsolidated subsidiaries | 22,881 |
| Other, net | -2,267 |
| Premiums receivable | -605 |
| Reinsurance related assets and liabilities | -36,440 |
| Other assets | -13,675 |
| Reserve for losses and loss adjustment expenses | -165,733 |
| Unearned premiums | -14,926 |
| Other liabilities | 3,805 |
| Net cash provided by (used in) operating activities | -25,620 |
| Fixed maturities, available-for-sale | 892,469 |
| Equity investments | 4,259 |
| Other investments | 3,060 |
| Investment in unconsolidated subsidiaries | 27,716 |
| Fixed maturities, available-for-sale | 903,483 |
| Equity investments | 27,283 |
| Other investments | 934 |
| Net sales or (purchases) of fixed maturities, trading | 1,742 |
| Return of invested capital from unconsolidated subsidiaries | 35,177 |
| Net sales or maturities (purchases) of short-term investments | 28,545 |
| Unsettled security transactions, net change | -1,292 |
| Purchases of capital assets | 3,598 |
| Proceeds from sale of capital assets | 19,308 |
| Net cash impact of deconsolidation of closed years of account from lloyd's syndicates operations | 11,102 |
| Other | -966 |
| Net cash provided by (used in) investing activities | 19,436 |
| Borrowings (repayments) under revolving credit agreement | -6,250 |
| Repayments of senior notes | 0 |
| Repurchase of common stock | 0 |
| Dividends to shareholders | 0 |
| Capital contribution received from (return of capital to) external segregated portfolio cell participants | -3,307 |
| Other | -2,646 |
| Net cash provided by (used in) financing activities | -12,203 |
| Increase (decrease) in cash and cash equivalents | -18,387 |
| Cash and cash equivalents at beginning of period | 54,881 |
| Cash and cash equivalents at end of period | 36,494 |
PROASSURANCE CORP (PRA)
PROASSURANCE CORP (PRA)